Package 27241-134-36

Brand: cholestyramine

Generic: cholestyramine
NDC Package

Package Facts

Identity

Package NDC 27241-134-36
Digits Only 2724113436
Product NDC 27241-134
Description

60 PACKET in 1 CARTON (27241-134-36) / 9 g in 1 PACKET (27241-134-21)

Marketing

Marketing Status
Marketed Since 2020-04-06
Brand cholestyramine
Generic cholestyramine
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "52a1ce3a-88e1-4902-990d-c57cf9735e42", "openfda": {"nui": ["N0000180292", "N0000175365"], "upc": ["0327241134210", "0327241134517"], "unii": ["4B33BGI082"], "rxcui": ["848943"], "spl_set_id": ["a0b64dfe-49bc-45d7-9281-9e9d6e296c40"], "pharm_class_epc": ["Bile Acid Sequestrant [EPC]"], "pharm_class_moa": ["Bile-acid Binding Activity [MoA]"], "manufacturer_name": ["Ajanta Pharma USA Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "60 PACKET in 1 CARTON (27241-134-36)  / 9 g in 1 PACKET (27241-134-21)", "package_ndc": "27241-134-36", "marketing_start_date": "20200406"}, {"sample": false, "description": "378 g in 1 BOTTLE (27241-134-51)", "package_ndc": "27241-134-51", "marketing_start_date": "20200406"}], "brand_name": "Cholestyramine", "product_id": "27241-134_52a1ce3a-88e1-4902-990d-c57cf9735e42", "dosage_form": "POWDER, FOR SUSPENSION", "pharm_class": ["Bile Acid Sequestrant [EPC]", "Bile-acid Binding Activity [MoA]"], "product_ndc": "27241-134", "generic_name": "Cholestyramine", "labeler_name": "Ajanta Pharma USA Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Cholestyramine", "active_ingredients": [{"name": "CHOLESTYRAMINE", "strength": "4 g/9g"}], "application_number": "ANDA211119", "marketing_category": "ANDA", "marketing_start_date": "20200406", "listing_expiration_date": "20261231"}